Abstract: A fluid treatment device and method are provided for generating an electric field across a gap between first and second electrode and for concentrating the electric field within a fluid treatment chamber located in the gap.
Abstract: A system includes a signal generator and a processor. The signal generator is configured to couple with a magnetic resonance transmitter coil. The processor is configured to execute instructions to control the signal generator. The instructions include forming a sequence of waveforms. The sequence is configured to generate spin relaxation in a fictitious field in a third rotating frame of reference based on at least one magnetic field component that arises based on an effective field in a second rotating frame of reference. The third rotating frame of reference is of a higher order than the second rotating frame of reference and the second rotating frame of reference is of a higher order than the first rotating frame of reference.
Type:
Grant
Filed:
March 25, 2010
Date of Patent:
April 26, 2011
Assignee:
Regents of the University of Minnesota
Inventors:
Timo Liimatainen, Michael G. Garwood, Dennis J. Sorce, Shalom Michaeli
Abstract: The present disclosure features, inter alia, receptor-targeting reagents (e.g., immunotoxic receptor-targeting reagents), which are useful in, e.g., methods of binding a receptor-targeting reagent to a cell and methods for treating a variety of disorders such as, but not limited to, cancers and inflammatory disorders. Also featured are methods, compositions, and kits useful for selecting an appropriate treatment modality for a subject (e.g., a subject with a cancer or inflammatory disorder) and/or treating a variety of disorders such as cell proliferative disorders.
Abstract: The present invention relates to methods for providing lysosomal enzymes to a subject by administering stem cells, preferably Multipotent Adult Progenitor Cells (MAPCs). The invention further relates to methods for treating lysosomal storage disorders by administering stem cells.
Type:
Grant
Filed:
June 2, 2006
Date of Patent:
April 19, 2011
Assignee:
Regents of the University of Minnesota
Inventors:
Bruce Blazer, Jakub Tolar, Catherine M. Verfaillie
Abstract: The present disclosure is generally directed to an embolic material which, in some embodiments, may be in the form of a microsphere or a plurality of microspheres. The embolic material generally comprises carboxymethyl chitosan (CCN) crosslinked with carboxymethyl cellulose (CMC). In some embodiments, the embolic material may further comprise a therapeutic agent, such as doxorubicin.
Abstract: Protein-polymer composite materials are provided according to embodiments of the present invention that include an admixture of a polymer resin, a surfactant and a non-aqueous organic solvent. An aqueous solution containing bioactive proteins is mixed with the admixture. The emulsion is mixed with a crosslinker to produce a curable composition. The curable composition is cured, thereby producing the protein-polymer composite material that is useful for facilitating removal of bioorganic stains.
Type:
Application
Filed:
September 27, 2010
Publication date:
March 31, 2011
Applicants:
TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC, REGENTS OF THE UNIVERSITY OF MINNESOTA, TOYOTA MOTOR CORPORATION
Abstract: A method of magnetic resonance imaging based on rapid acquisition by sequential excitation and refocusing is provided. The method comprises turning on a first time-encoding gradient and applying an excitation pulse in the presence of the first time-encoding gradient. The excitation pulse excites magnetization sequentially along one spatial axis. Thereafter, a first refocusing pulse is applied. A second time-encoding gradient is turned on followed by a second refocusing pulse. A third time-encoding gradient is turned on and a signal is acquired in the presence of the third time-encoding gradient. The third time-encoding gradient sums to zero with the first time-encoding gradient and the second time-encoding gradient for sequential points in space.
Type:
Application
Filed:
August 16, 2010
Publication date:
March 24, 2011
Applicant:
Regents of the University of Minnesota
Inventors:
Ryan Chamberlain, Jang-Yeon Park, Michael G. Garwood
Abstract: The invention relates to methods and materials involved in diagnosing SLE. More particularly, the invention relates to methods and materials involved in diagnosing SLE, diagnosing severe SLE, and assessing a mammal's susceptibility to develop severe SLE. For example, the invention provides nucleic acid arrays that can be used to diagnose SLE in a mammal. Such arrays can allow clinicians to diagnose SLE based on a simultaneous determination of the expression levels of many genes that are differentially expressed in SLE patients as compared to healthy controls.
Type:
Grant
Filed:
October 3, 2006
Date of Patent:
March 22, 2011
Assignees:
Regents of the University of Minnesota, The Feinstein Institute for Medical Research
Inventors:
Timothy W. Behrens, Emily C. Baechler, Peter K. Gregersen
Abstract: A continuous flow bioreactor system that includes a bioreactor, an optional post-bioreactor preparation chamber, a cell sorter, and an optional pre-bioreactor preparation chamber in a closed loop, useful for enriching a heterogeneous cell population growing in the bioreactor with an isolated subpopulation of cells.
Type:
Grant
Filed:
November 3, 2008
Date of Patent:
March 8, 2011
Assignee:
Regents of the University of Minnesota
Inventors:
Friedrich Srienc, Abdelqader Zamamiri, Nicholas R. Abu-Absi, James A. Kacmar
Abstract: A navigation system or combination of navigation systems can be used to provide two or more navigation modalities to navigate a single instrument in a volume. For example, both an Electromagnetic (EM) and Electropotential (EP) navigation system can be used to navigate an instrument within the volume. Image data can also be illustrated relative to a tracked position of the instrument in the volume for navigation.
Type:
Application
Filed:
July 27, 2010
Publication date:
March 3, 2011
Applicants:
Medtronic, Inc., Regents of the University of Minnesota
Inventors:
H. Toby Markowitz, Kenneth Gardeski, Jean Carver, Kendra Yasger, Michael R. Neldert, Lane A. Phillips, Laurent Verard, Steven L. Hartmann, Andrew Bzostek, Bradley A. Jascob
Abstract: Methods and reactors for producing a fuel are disclosed herein. In some embodiments, the method uses a biomass feedstock and alkane and/or alcohol feedstock, which can be contacted with a metal-containing catalyst to form products including a bio-oil. In some embodiments, oxygen-containing functional groups can be removed from a bio-oil using one or more zeolite thin films.
Type:
Application
Filed:
August 30, 2010
Publication date:
March 3, 2011
Applicant:
Regents of the University of Minnesota
Inventors:
Aditya Bhan, Michael Tsapatsis, Lanny D. Schmidt, Paul J. Dauenhauer
Abstract: The present invention provides isolated polynucleotides and isolated polypeptides. The polypeptides of the present invention have isoprenoid wax ester synthase activity or isoprenoid acyl CoA-synthetase activity. The present invention also includes methods of using the polynucleotides and polypeptides of the present invention. For instance, the methods include producing biodiesel and producing wax esters.
Type:
Grant
Filed:
August 27, 2008
Date of Patent:
March 1, 2011
Assignee:
Regents of the University of Minnesota
Inventors:
Claudia Schmidt-Dannert, Erik K. Holtzapple
Abstract: Embodiments of the present invention are directed to a physiological monitoring device which is configured to record signals that reflect blood flow and/or blood pressure, and which may also record ECG signals. In one embodiment, a portable monitoring device comprises a plurality of impedance electrodes configured to be coupled to a patient's body and to generate an AC current with an electrical field to detect local electrical impedance of a portion of the patient's body encompassed by the electrical field, the local electrical impedance being a surrogate measure of local blood flow of the portion of the patient's body. At least a portion of the portable monitoring device is configured to be insertable subcutaneously into the patient's body.
Type:
Grant
Filed:
May 10, 2005
Date of Patent:
March 1, 2011
Assignee:
Regents of the University of Minnesota
Inventors:
David G. Benditt, Robert F. Patterson, Keith G. Lurie
Abstract: Nanodispersions of inorganic clays in isocyanate may be created via pre-exfoliation, delamination, or both of the clay and subsequent mixing with isocyanate. In an embodiment, such an isocyanate nanodispersion is reacted with an isocyanate-reactive material or substrate to form a polyurethane nanocomposite.
Type:
Application
Filed:
May 6, 2009
Publication date:
February 24, 2011
Applicants:
HUNTSMAN INTERNATIONAL LLC, REGENTS OF THE UNIVERSITY OF MINNESOTA
Inventors:
G. Harikrishnan, Christopher Ward Macosko, Christopher Ian Lindsay, Sachchida Nand Singh
Abstract: A method includes receiving data corresponding to a sequence of deformations of a surface of an object. The method also includes generating spherical harmonics expressions based on the data. The method includes identifying a subspace of the spherical harmonics expression corresponding to the surface.
Type:
Application
Filed:
June 23, 2010
Publication date:
February 24, 2011
Applicant:
Regents of the University of Minnesota
Inventors:
Ahmed H. Tewfik, Dan Wang, Timothy Kinney
Abstract: An apparatus comprises a radio frequency magnetic field unit to generate a desired magnetic field. In one embodiment, the radio frequency magnetic field unit includes a first aperture that is substantially unobstructed and a second aperture contiguous to the first aperture. In an alternative embodiment, the radio frequency magnetic field unit includes a first side aperture, a second side aperture and one or more end apertures. In one embodiment of a method, a current element is removed from a radio frequency magnetic field unit to form a magnetic field unit having an aperture. In an alternative embodiment, two current elements located opposite from one another in a radio frequency magnetic field unit are removed to form a magnetic filed unit having a first side aperture and a second side aperture.
Type:
Grant
Filed:
May 1, 2006
Date of Patent:
February 22, 2011
Assignee:
Regents of the University of Minnesota
Inventors:
J. Thomas Vaughan, Gregor Adriany, Kamil Ugurbil
Abstract: In an error correction method, a codeword is transmitted through a noisy communication channel and detected by a receiving device. An error detection code is then applied to the detected codeword to generate a syndrome. Where the syndrome is not all zero, the codeword is determined to contain some error. Accordingly, the method computes a set of potential error start positions for a plurality of error events based on a syndrome value corresponding to the syndrome. Next, a confidence value is computed for each of the plurality of error events at each of the potential error start positions in the refined set, and finally, a most likely error event in the detected codeword is corrected based on an error event and corresponding potential error start position having the highest confidence value.
Type:
Grant
Filed:
November 14, 2006
Date of Patent:
February 15, 2011
Assignees:
Samsung Electronics Co., Ltd., Regents of the University of Minnesota
Abstract: An estimated current phase error is used to control the oscillation frequency of a voltage controlled oscillator used to control the timing of sampling operations performed by an analog to digital converter (ADC). The current phase error is calculated by a recursive computation using a previous phase error in order to eliminate noise effects from the current phase error.
Type:
Grant
Filed:
November 14, 2006
Date of Patent:
February 15, 2011
Assignees:
Samsung Electronics Co., Ltd., Regents of the University of Minnesota
Abstract: The present invention provides swine cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple cell types. Also provided are methods of isolation and culture, as well as uses for the cells, such as xenogeneic transplantation and/or tissue repair.
Type:
Grant
Filed:
March 20, 2007
Date of Patent:
February 8, 2011
Assignee:
Regents of the University of Minnesota
Inventors:
Catherine M. Verfaillie, Lepeng Zeng, Jianyi Zhang